Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.125
Bid: 10.75
Ask: 11.50
Change: 0.00 (0.00%)
Spread: 0.75 (6.977%)
Open: 11.125
High: 11.125
Low: 11.125
Prev. Close: 11.125
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Prezzo exec slices off 200,000 shares

Tue, 22nd Oct 2013 16:26

Kuldip Sehmi, an Executive Director at Italian restaurant chain Prezzo, on Monday traded in 200,000 shares, reducing his stake to 682,244 shares, equal to 0.29 per cent of the issued share capital. Sehmi, who is responsible for the day to day running of approximately half the Prezzo estate, sold the shares at 117p each for a total trade value of £234,000. While significant, the size of the transaction pales in comparison to that made by Jonathan Kaye, the group's Chief Executive Officer, and two of its Non-Executive Directors, last month, when they each traded in a 1.3m share slice of the company. At the beginning of September, the group posted a 17% leap in half year revenue to £79.7m, while adjusted pre-tax profit climbed 12% to £8.5m, and said it was "confident of delivering a satisfactory outcome for the year as a whole".Top Director BuysAberforth Geared Income Trust (AGIT) Director name: Mr Graham R MenziesAmount purchased: 49,865 @ 158.12p Value: £78,847JPMorgan European Inv Trust Growth Shares (JETG) Director name: Mr Andrew AdcockAmount purchased: 25,000 @ 217.50p Value: £54,375STV Group (STVG) Director name: Mr Genevieve Shore Amount purchased: 5,564 @ 264.75p Value: £14,731Top Director SellsGLOBO (GBO) Director name: Mr Gavin BurnellAmount sold: 505,000 @ 71.00p Value: £358,550Prezzo (PRZ) Director name: Mr Kuldip SehmiAmount sold: 200,000 @ 117.00p Value: £234,000GLOBO (GBO) Director name: Mr Gerasimos (Makis) BonanosAmount sold: 250,000 @ 71.00p Value: £177,500GLOBO (GBO) Director name: Mr Dimitrios GryparisAmount sold: 245,000 @ 71.00p Value: £173,950Dairy Farm International Holdings Ltd. (Singapore) (DFI) Director name: Mr Michael KokAmount sold: 13,500 @ $11.13 Value: $150,246Dillistone Group (DSG) Director name: Mr Giles Robin Fearnley Amount sold: 150,000 @ 100.10p Value: £150,150Scancell Holdings (SCLP) Director name: Dr Richard GoodfellowAmount sold: 100,000 @ 30.00p Value: £30,000Scancell Holdings (SCLP) Director name: Professor Lindy DurrantAmount sold: 100,000 @ 30.00p Value: £30,000Dunedin Enterprise Investment Trust (DNE) Director name: Mr Liz AireyAmount sold: 2,500 @ 475.00p Value: £11,875
More News
1 Nov 2021 06:57

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors

IN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors

Read more
29 Oct 2021 20:28

TRADING UPDATES: Asia Dragon beats benchmark, Henderson Far East lags

TRADING UPDATES: Asia Dragon beats benchmark, Henderson Far East lags

Read more
22 Oct 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Oct 2021 20:41

IN BRIEF: Scancell bases new facility at Oxford Science Park

IN BRIEF: Scancell bases new facility at Oxford Science Park

Read more
5 Oct 2021 22:03

IN BRIEF: Scancell doses first subject in Covidity phase one trial

IN BRIEF: Scancell doses first subject in Covidity phase one trial

Read more
26 Aug 2021 12:53

TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV

TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV

Read more
26 Aug 2021 12:38

Scancell gets MHRA approval for Modi-1 clinical trial

(Sharecast News) - Immunotherapy developer Scancell announced on Thursday that the UK Medicines and Healthcare products Regulatory Authority (MHRA) has approved the clinical trial application to initiate the first-in-human phase 1 and 2 clinical study of 'Modi-1'.

Read more
17 Aug 2021 15:32

Scancell chooses needle-free tech for Covid vaccine candidates

(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell has selected the PharmaJet needle-free injection system to administer its two SARS-CoV-2 vaccine candidates for Covid-19, 'SCOV1' and 'SCOV2', in its 'COVIDITY' phase 1 clinical trial, it announced on Tuesday.

Read more
30 Jul 2021 14:24

DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares

DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares

Read more
29 Jul 2021 22:08

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

Read more
28 Jul 2021 22:00

IN BRIEF: Scancell turns once again to Durrant to lead company

IN BRIEF: Scancell turns once again to Durrant to lead company

Read more
22 Jun 2021 15:21

Scancell makes progress with 'Covidity' trial plans

(Sharecast News) - Immunotherapy developer Scancell updated the market on 'Covidity' clinical trial plans, and the publication of preclinical data on two vaccine candidates from the research programme.

Read more
22 Jun 2021 12:14

IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK

IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK

Read more
7 Jun 2021 13:58

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares

Read more
7 Jun 2021 10:38

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.